Canaccord Genuity Maintains Buy on Artivion, Raises Price Target to $40
Artivion, Inc.
Artivion, Inc. AORT | 0.00 |
Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:
AORT) with a Buy and raises the price target from $39 to $40.